Abstract
Some 12 years ago, a polymorphism of the angiotensin I-converting enzyme (ACE) gene became the first genetic element shown to impact substantially on human physical performance. The renin-angiotensin system (RAS) exists not just as an endocrine regulator, but also within local tissue and cells, where it serves a variety of functions. Functional genetic polymorphic variants have been identified for most components of RAS, of which the best known and studied is a polymorphism of the ACE gene. The ACE insertion/deletion (I/D) polymorphism has been associated with improvements in performance and exercise duration in a variety of populations. The I allele has been consistently demonstrated to be associated with endurance-orientated events, notably, in triathlons. Meanwhile, the D allele is associated with strength- and power-orientated performance, and has been found in significant excess among elite swimmers. Exceptions to these associations do exist, and are discussed.
In theory, associations with ACE genotype may be due to functional variants in nearby loci, and/or related genetic polymorphism such as the angiotensin receptor, growth hormone and bradykinin genes. Studies of growth hormone gene variants have not shown significant associations with performance in studies involving both triathletes and military recruits. The angiotensin type-1 receptor has two functional polymorphisms that have not been shown to be associated with performance, although studies of hypoxic ascent have yielded conflicting results. ACE genotype influences bradykinin levels, and a common gene variant in the bradykinin 2 receptor exists. The high kinin activity haplotye has been associated with increased endurance performance at an Olympic level, and similar results of metabolic efficiency have been demonstrated in triathletes.
Whilst the ACE genotype is associated with overall performance ability, at a single organ level, the ACE genotype and related polymorphism have significant associations. In cardiac muscle, ACE genotype has associations with left ventricular mass changes in response to stimulus, in both the health and diseased states. The D allele is associated with an exaggerated response to training, and the I allele with the lowest cardiac growth response. In light of the I-allele association with endurance performance, it seems likely that other regulatory mechanisms exist. Similarly in skeletal muscle, the D allele is associated with greater strength gains in response to training, in both healthy individuals and chronic disease states. As in overall performance, those genetic polymorphisms related to the ACE genotype, such as the bradykinin 2 gene, also influence skeletal muscle strength.
Finally, the ACE genotype may influence metabolic efficiency, and elite mountaineers have demonstrated an excess of I alleles and I/I genotype frequency in comparison to controls. Interestingly, this was not seen in amateur climbers. Corroboratory evidence exists among high-altitude settlements in both South America and India, where the I allele exists in greater frequency in those who migrated from the lowlands. Unfortunately, if the ACE genotype does influence metabolic efficiency, associations with peak maximal oxygen consumption have yet to be rigorously demonstrated.
The ACE genotype is an important but single factor in the determinant of sporting phenotype. Much of the mechanisms underlying this remain unexplored despite 12 years of research.
Similar content being viewed by others
References
Montgomery HE, Marshall R, Marshall R, et al. Human gene for physical performance. Nature 1998; 393 (6682): 221–2
Timmermans PB, Smith RD. Angiotensin II receptor subtypes: selective antagonists and functional correlates. Eur Heart J 1994; 15 Suppl.D: 79–87
Dendorfer A, Wolfrum S, Wolfrum S, et al. Pathways of bradykinin degradation in blood and plasma of normotensiveand hypertensive rats. Am J Physiol Heart Circ Physiol 2001; 280 (5): H2182–8
Regoli D, Nsa Allogho S, Rizzi A, et al. Bradykinin receptors and their antagonists. Eur J Pharmacol 1998; 348 (1): 1–10
Brown NJ, Blais Jr C, Gandhi SK, et al. ACE insertion/ deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 1998; 32 (3): 373–7
Murphey LJ, Gainer JV, Vaughan DE, et al. Angiotensinconverting enzyme insertion/deletion polymorphismmodulates the human in vivo metabolism of bradykinin. Circulation 2000; 102 (8): 829–32
Kem DC, Brown RD. Renin: from beginning to end. N Engl J Med 1990; 323 (16): 1136–7
Dzau VJ. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J Hypertens 1989; 7 (12): 933–6
Nazarov IB, Woods DR, Montgomery HE, et al. The angiotensin converting enzyme I/D polymorphism inRussian athletes. Eur J Hum Genet 2001; 9 (10): 797–801
Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86 (3): 747–803
Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-convertingenzyme gene accounting for half the variance of serumenzyme levels. J Clin Invest 1990; 86 (4): 1343–6
Costerousse O, Allegrini J, Lopez M, et al. Angiotensin Iconverting enzyme in human circulating mononuclearcells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290 (Pt1): 33–40
Danser AH, Schalekamp MA, Bax WA, et al. Angiotensinconverting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92 (6): 1387–8
Villard E, Tiret L, Visvikis S, et al. Identification of new polymorphisms of the angiotensin I-converting enzyme(ACE) gene, and study of their relationship to plasmaACE levels by two-QTL segregation-linkage analysis. AmJ Hum Genet 1996; 58 (6): 1268–78
Jeunemaitre X, Lifton RP, Hunt SC, et al. Absence of linkage between the angiotensin converting enzyme locusand human essential hypertension. Nat Genet 1992; 1 (1): 72–5
Jeunemaitre X, Rigat B, Charru A, et al. Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992; 88 (3): 301–6
Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71 (1): 169–80
Ishigami T, Umemura S, Tamura K, et al. Essential hypertension and 50 upstream core promoter region of humanangiotensinogen gene. Hypertension 1997; 30 (6): 1325–30
Sato N, Katsuya T, Rakugi H, et al. Association of variants in critical core promoter element of angiotensinogen genewith increased risk of essential hypertension in Japanese. Hypertension 1997; 30 (3Pt1): 321–5
Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen isassociated with essential hypertension and affects basaltranscription in vitro. J Clin Invest 1997; 99 (7): 1786–97
Paillard F, Chansel D, Brand E, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone systemin a normal population. Hypertension 1999; 34 (3): 423–9
Mansego ML, Redon J, Marin R, et al. Renin polymorphisms and haplotypes are associated with bloodpressure levels and hypertension risk in postmenopausalwomen. J Hypertens 2008; 26 (2): 230–7
Poirier O, Georges JL, Ricard S, et al. New polymorphisms of the angiotensin II type 1 receptor gene and their associationswith myocardial infarction and blood pressure:the ECTIM study. Etude Cas-Temoin de l’Infarctus duMyocarde J Hypertens 1998; 16 (10): 1443–7
Miller JA, Thai K, Scholey JW. Angiotensin II type 1 receptor gene polymorphism predicts response to losartanand angiotensin II. Kidney Int 1999; 56 (6): 2173–80
Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin II type 1 receptor gene polymorphisms in humanessential hypertension. Hypertension 1994; 24 (1): 63–9
Martin MM, Elton TS. The sequence and genomic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun 1995; 209 (2): 554–62
Alhenc-Gelas F, Richard J, Courbon D, et al. Distribution of plasma angiotensin I-converting enzyme levels inhealthymen: relationship to environmental and hormonalparameters. J Lab Clin Med 1991; 117 (1): 33–9
Woods D, Onambele G, Woledge R, et al. Angiotensin-I converting enzyme genotype-dependent benefit fromhormone replacement therapy in isometric musclestrength and bone mineral density. J Clin Endocrinol Metab 2001; 86 (5): 2200–4
Myerson S, Hemingway H, Budget R, et al. Human angiotensin I-converting enzyme gene and enduranceperformance. J Appl Physiol 1999; 87 (4): 1313–6
Tsianos G, Sanders J, Dhamrait S, et al. The ACE gene insertion/deletion polymorphism and elite enduranceswimming. Eur J Appl Physiol 2004; 92 (3): 360–2
Gayagay G, Yu B, Hambly B, et al. Elite endurance athletes and the ACE I allele: the role of genes in athleticperformance. Hum Genet 1998; 103 (1): 48–50
Alvarez R, Terrados N, Ortolano R, et al. Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 2000; 82 (1-2): 117–20
Collins M, Xenophontos SL, Cariolou MA, et al. The ACE gene and endurance performance during the South African Ironman Triathlons. Med Sci Sports Exerc 2004; 36 (8): 1314–20
Woods D, Hickman M, Jamshidi Y, et al. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet 2001; 108 (3): 230–2
Costa A, Silva A, Garrido N, et al. Association between ACE D allele and elite short distance swimming. EurJ Appl Physiol 2009; 106 (6): 785–90
Rankinen T, Wolfarth B, Simoneau JA, et al. No association between the angiotensin-converting enzyme IDpolymorphism and elite endurance athlete status. J Appl Physiol 2000; 88 (5): 1571–5
Montgomery H, Dhamrait S. ACE genotype and performance. J Appl Physiol 2002; 92 (4): 1774–5; author reply1776-7
Woods DR, Humphries SE, Montgomery HE. The ACE I/D polymorphism and human physical performance. Trends Endocrinol Metab 2000; 11 (10): 416–20
Sonna LA, Sharp MA, Knapik JJ, et al. Angiotensinconverting enzyme genotype and physical performanceduring US Army basic training. J Appl Physiol 2001; 91 (3): 1355–63
Karjalainen J, Kujala UM, Stolt A, et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophyin endurance athletes. J Am Coll Cardiol 1999; 34 (2): 494–9
Taylor RR, Mamotte CD, Fallon K, et al. Elite athletes and the gene for angiotensin-converting enzyme. J Appl Physiol 1999; 87 (3): 1035–7
Amir O, Amir R, Yamin C, et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol 2007; 92 (5): 881–6
Zoossmann-Diskin A. The association of the ACE gene and elite athletic performance in Israel may be an artifact. Exp Physiol 2008; 93 (11): 1220; author reply 1221
Kim CH, Cho JY, Jeon JY, et al. ACE DD genotype is unfavorable to Korean short-term muscle power athletes. Int J Sports Med 2010; 31 (1): 65–71
Cam FS, Colakoglu M, Sekuri C, et al. Association between the ACE I/D gene polymorphism and physicalperformance in a homogeneous non-elite cohort. Can JAppl Physiol 2005; 30 (1): 74–86
Cerit M, Colakoglu M, Erdogan M, et al. Relationship between ace genotype and short duration aerobic performancedevelopment. Eur J Appl Physiol 2006; 98 (5): 461–5
Colakoglu M, Cam FS, Kayitken B, et al. ACE genotype may have an effect on single versus multiple set preferencesin strength training. Eur J Appl Physiol 2005; 95 (1): 20–6
Juffer P, Furrer R, Gonzalez-Freire M, et al. Genotype distributions in top-level soccer players: a role for ACE? Int J Sports Med 2009; 30 (5): 387–92
Lucia A, Gomez-Gallego F, Chicharro JL, et al. Is there an association between ACE and CKMM polymorphismsand cycling performance status during 3-week races? Int J Sports Med 2005; 26 (6): 442–7
Muniesa CA, Gonzalez-Freire M, Santiago C, et al. Worldclass performance in lightweight rowing: is it geneticallyinfluenced? A comparison with cyclists, runners and nonathletes. Br J Sports Med 2010; 44 (12): 898–901
Winnicki M, Accurso V, Hoffmann M, et al. Physical activity and angiotensin-converting enzyme gene polymorphismin mild hypertensives. Am J Med Genet A 2004; 125A (1): 38–44
Costa AM, Silva AJ, Garrido ND, et al. Association between ACE D allele and elite short distance swimming. Eur J Appl Physiol 2009; 106 (6): 785–90
Giaccaglia V, Nicklas B, Kritchevsky S, et al. Interaction between angiotensin converting enzyme insertion/deletiongenotype and exercise training on knee extensor strengthin older individuals. Int J Sports Med 2008; 29 (1): 40–4
Zhao B, Moochhala SM, Tham S, et al. Relationship between angiotensin-converting enzyme ID polymorphismand VO(2max) of Chinese males. Life Sci 2003; 73 (20): 2625–30
Tsianos G, Eleftheriou KI, Hawe E, et al. Performance at altitude and angiotensin I-converting enzyme genotype. Eur J Appl Physiol 2005; 93 (5-6): 630–3
Hruskovicova H, Dzurenkova D, Selingerova M, et al. The angiotensin converting enzyme I/D polymorphism in longdistance runners. J Sports Med Phys Fitness 2006; 46 (3): 509–13
Cieszczyk P, Krupecki K, Maciejewska A, et al. The angiotensin converting enzyme gene I/D polymorphism inpolish rowers. Int J Sports Med 2009; 30 (8): 624–7
Min SK, Takahashi K, Ishigami H, et al. Is there a gender difference between ACE gene and race distance? Appl Physiol Nutr Metab 2009; 34 (5): 926–32
Cam S, Colakoglu M, Colakoglu S, et al. ACE I/D gene polymorphism and aerobic endurance development inresponse to training in a non-elite female cohort. J Sports Med Phys Fitness 2007; 47 (2): 234–8
Moran CN, Vassilopoulos C, Tsiokanos A, et al. The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents. Eur J Hum Genet 2006; 14 (3): 332–9
Thompson J, Raitt J, Hutchings L, et al. Angiotensinconverting enzyme genotype and successful ascent to extremehigh altitude. High Alt Med Biol 2007; 8 (4): 278–85
Hurlbut DE, Lott ME, Ryan AS, et al. Does age, sex, or ACE genotype affect glucose and insulin responses tostrength training? J Appl Physiol 2002; 92 (2): 643–50
Dekany M, Harbula I, Berkes I, et al. The role of insertion allele of angiotensin converting enzyme gene in higherendurance efficiency and some aspects of pathophysio-logical and drug effects. Curr Med Chem 2006; 13 (18): 2119–26
Williams AG, Rayson MP, Jubb M, et al. The ACE gene and muscle performance [letter]. Nature 2000; 403 (6770): 614
Kritchevsky SB, Nicklas BJ, Visser M, et al. Angiotensinconverting enzyme insertion/deletion genotype, exercise,and physical decline. JAMA 2005; 294 (6): 691–8
Goh KP, Chew K, Koh A, et al. The relationship between ACE gene IDpolymorphism and aerobic capacity in Asianrugby players. Singapore Med J 2009; 50 (10): 997–1003
Turgut G, Turgut S, Genc O, et al. The angiotensin converting enzyme I/D polymorphism in Turkish athletes andsedentary controls. Acta Medica (Hradec Kralove) 2004; 47 (2): 133–6
Scott RA, Irving R, Irwin L, et al. ACTN3 and ACE genotypes in elite Jamaican and US sprinters. Med Sci Sports Exerc 2010; 42 (1): 107–12
Frederiksen H, Bathum L, Worm C, et al. ACE genotype and physical training effects: a randomized study amongelderly Danes. Aging Clin Exp Res 2003; 15 (4): 284–91
Scott RA, Moran C, Wilson RH, et al. No association between angiotensin converting enzyme (ACE) gene variationand endurance athlete status in Kenyans. Comp Biochem Physiol A Mol Integr Physiol 2005; 141 (2): 169–75
Day SH, Gohlke P, Dhamrait SS, et al. No correlation between circulating ACE activity and. VO2max or mechanicalefficiency in women Eur J Appl Physiol 2007; 99 (1): 11–8
Oh SD. The distribution of I/D polymorphism in the ACE gene among Korean male elite athletes. J Sports Med Phys Fitness 2007; 47 (2): 250–4
Papadimitriou ID, Papadopoulos C, Kouvatsi A, et al. The ACE I/D polymorphism in elite Greek track and fieldathletes. J Sports Med Phys Fitness 2009; 49 (4): 459–63
Thomis MA, Huygens W, Heuninckx S, et al. Exploration of myostatin polymorphisms and the angiotensin-convertingenzyme insertion/deletion genotype in responsesof human muscle to strength training. Eur J Appl Physiol 2004; 92 (3): 267–74
McCauley T, Mastana SS, Hossack J, et al. Human angiotensin-converting enzyme I/D and alpha-actinin 3R577X genotypes and muscle functional and contractileproperties. Exp Physiol 2009; 94 (1): 81–9
Bennani-Baiti IM, Jones BK, Liebhaber SA, et al. Physical linkage of the human growth hormone gene cluster andthe skeletal muscle sodium channel alpha-subunit gene(SCN4A) on chromosome 17. Genomics 1995; 29 (3): 647–52
Hasegawa Y, Fujii K, Yamada M, et al. Identification of novel human GH-1 gene polymorphisms that are associatedwith growth hormone secretion and height. J Clin Endocrinol Metab 2000; 85 (3): 1290–5
Walpole B, Noakes TD, Collins M. Growth hormone 1 (GH1) gene and performance and post-race rectal temperatureduring the South African Ironman triathlon. Br J Sports Med 2006; 40 (2): 145–50; discussion 145–50
Huang S, Chen XH, Payne JR, et al. Haplotype of growth hormone and angiotensin I-converting enzyme genes,serum angiotensin I-converting enzyme and ventriculargrowth: pathway inference in pharmacogenetics. Pharmacogenet Genomics 2007; 17 (4): 291–4
Berge KE, Bakken A, Bohn M, et al. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locusand myocardial infarction. Clin Genet 1997; 52 (2): 71–6
Diet F, Graf C, Mahnke N, et al. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes. Eur J Clin Invest 2001; 31 (10): 836–42
Delmonico MJ, Ferrell RE, Meerasahib A, et al. Blood pressure response to strength training may be influencedby angiotensinogen A-20C and angiotensin II type I receptorA1166C genotypes in older men and women. J Am Geriatr Soc 2005; 53 (2): 204–10
Fatini C, Guazzelli R, Manetti P, et al. RAS genes influence exercise-induced left ventricular hypertrophy: an eliteathletes study. Med Sci Sports Exerc 2000; 32 (11): 1868–72
Bae JS, Kang BY, Lee KO, et al. Genetic variation in the renin-angiotensin system and response to endurancetraining. Med Princ Pract 2007; 16 (2): 142–6
Hotta J, Hanaoka M, Droma Y, et al. Polymorphisms of renin-angiotensin system genes with high-altitude pulmonaryedema in Japanese subjects. Chest 2004; 126 (3): 825–30
Koehle MS, Wang P, Guenette JA, et al. No association between variants in the ACE and angiotensin II receptor 1genes and acute mountain sickness in Nepalese pilgrims tothe Janai Purnima Festival at 4380 m. High Alt Med Biol 2006; 7 (4): 281–9
Houle S, Landry M, Audet R, et al. Effect of allelic polymorphism of the B(1) and B(2) receptor genes on thecontractile responses of the human umbilical vein to kinins. J Pharmacol Exp Ther 2000; 294 (1): 45–51
Lung CC, Chan EK, Zuraw BL. Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and itstranscript in normal subjects and patients with C1 inhibitordeficiency. J Allergy Clin Immunol 1997; 99 (1Pt1): 134–46
Williams AG, Dhamrait SS, Wootton PT, et al. Bradykinin receptor gene variant and human physical performance. J Appl Physiol 2004; 96 (3): 938–42
Saunders CJ, Xenophontos SL, Cariolou MA, et al. The bradykinin {beta}2 receptor (BDKRB2) and endothelialnitric oxide synthase 3 (NOS3) genes and endurance performanceduring ironman triathlons. Hum Mol Genet 2006; 15 (6): 979–87
Yamin C, Amir O, Sagiv M, et al. ACE ID genotype affects blood creatine kinase response to eccentric exercise. J Appl Physiol 2007; 103 (6): 2057–61
Liu Y, Leri A, Li B, et al. Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricularmyocytes. Circ Res 1998; 82 (11): 1145–59
Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999; 43 (4): 838–49
Danser AH, Saris JJ, Schuijt MP, et al. Is there a local renin-angiotensin system in the heart? Cardiovasc Res 1999; 44 (2): 252–65
Schunkert H, Dzau VJ, Tang SS, et al. Increased rat cardiac angiotensin converting enzyme activity and mRNA expressionin pressure overload left ventricular hypertrophy:effects on coronary resistance, contractility, and relaxation. J Clin Invest 1990; 86 (6): 1913–20
Beinlich CJ, White GJ, Baker KM, et al. Angiotensin II and left ventricular growth in newborn pig heart. J Mol Cell Cardiol 1991; 23 (9): 1031–8
Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a metaanalysisof randomized double-blind studies. JAMA 1996; 275 (19): 1507–13
Cruickshank JM, Lewis J, Moore V, et al. Reversibility of left ventricular hypertrophy by differing types of antihypertensivetherapy. J Hum Hypertens 1992; 6 (2): 85–90
Schmieder RE, Schlaich MP, Klingbeil AU, et al. Update on reversal of left ventricular hypertrophy in essentialhypertension (a meta-analysis of all randomized doubleblindstudies until December 1996). Nephrol Dial Transplant 1998; 13 (3): 564–9
Buhl R, Ersboll AK, Eriksen L, et al. Changes over time in echocardiographic measurements in young standardbredracehorses undergoing training and racing and associationwith racing performance. J Am Vet Med Assoc 2005; 226 (11): 1881–7
Young LE. Equine athletes, the equine athlete’s heart and racing success. Exp Physiol 2003; 88 (5): 659–63
Young LE, Rogers K, Wood JL. Left ventricular size and systolic function in thoroughbred racehorses and theirrelationships to race performance. J Appl Physiol 2005; 99 (4): 1278–85
Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphismwith change in left ventricular mass in responseto physical training. Circulation 1997; 96 (3): 741–7
Di Mauro M, Izzicupo P, Santarelli F, et al. ACE and AGTR1 polymorphisms and left ventricular hypertrophy inendurance athletes. Med Sci Sports Exerc 2010; 42 (5): 915–21
Kasikcioglu E, Kayserilioglu A, Ciloglu F, et al. Angiotensinconverting enzyme gene polymorphism, left ventricularremodeling, and exercise capacity in strength-trainedathletes. Heart Vessels 2004; 19 (6): 287–93
Hernandez D, de la Rosa A, Barragan A, et al. The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes. J Am Coll Cardiol 2003; 42 (3): 527–32
Lindpaintner K, Lee M, Larson MG, et al. Absence of association or genetic linkage between the angiotensinconverting-enzyme gene and left ventricular mass. N EnglJ Med 1996; 334 (16): 1023–8
Staessen JA, Wang JG, Ginocchio G, et al. The deletion/insertion polymorphism of the angiotensin convertingenzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15 (12 Pt 2): 1579–92
Yildiz A, Akkaya V, Hatemi AC, et al. No association between deletion-type angiotensin-converting enzyme genepolymorphism and left-ventricular hypertrophy in hemodialysispatients. Nephron 2000; 84 (2): 130–5
Dursunoglu D, Evrengul H, Tanriverdi H, et al. Angiotensin- converting enzyme polymorphism in healthyyoung subjects: relationship to left ventricular mass andfunctions. Acta Cardiol 2005; 60 (2): 153–8
Rizzo M, Gensini F, Fatini C, et al. ACE I/D polymorphism and cardiac adaptations in adolescent athletes. Med Sci Sports Exerc 2003; 35 (12): 1986–90
Estacio RO, Jeffers BW, Havranek EP, et al. Deletion polymorphism of the angiotensin converting enzyme geneis associated with an increase in left ventricular mass inmen with type 2 diabetes mellitus. Am J Hypertens 1999; 12 (6): 637–42
Kuznetsova T, Staessen JA, Wang JG, et al. Antihypertensive treatment modulates the association betweenthe D/I ACE gene polymorphism and left ventricular hypertrophy:a meta-analysis. J Hum Hypertens 2000; 14 (7): 447–54
Yoneya K, Okamoto H, Machida M, et al. Angiotensinconverting enzyme gene polymorphism in Japanesepatients with hypertrophic cardiomyopathy. Am HeartJ 1995; 130 (5): 1089–93
Dellgren G, Eriksson MJ, Blange I, et al. Angiotensinconverting enzyme gene polymorphism influences degreeof left ventricular hypertrophy and its regression inpatients undergoing operation for aortic stenosis. AmJ Cardiol 1999; 84 (8): 909–13
Ashley EA, Kardos A, Jack ES, et al. Angiotensin-converting enzyme genotype predicts cardiac and autonomicresponses to prolonged exercise. J Am Coll Cardiol 2006; 48 (3): 523–31
Tanriverdi H, Evrengul H, Kaftan A, et al. Effects of angiotensin-converting enzyme polymorphism on aorticelastic parameters in athletes. Cardiology 2005; 104 (3): 113–9
Myerson SG, Montgomery HE, Whittingham M, et al. Left ventricular hypertrophy with exercise and ACE geneinsertion/deletion polymorphism: a randomized controlledtrial with losartan. Circulation 2001; 103 (2): 226–30
Hallberg P, Lind L, Michaelsson K, et al. B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricularmass in response to anti hypertensive treatment:results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. J Hypertens 2003; 21 (3): 621–4
Brull D, Dhamrait S, Myerson S, et al. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet 2001; 358 (9288): 1155–6
Folland J, Leach B, Little T, et al. Angiotensin-converting enzyme genotype affects the response of human skeletalmuscle to functional overload. Exp Physiol 2000; 85 (5): 575–9
Williams AG, Day SH, Folland JP, et al. Circulating angiotensin converting enzyme activity is correlated withmuscle strength. Med Sci Sports Exerc 2005; 37 (6): 944–8
Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronicobstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170 (4): 395–9
Zhang B, Tanaka H, Shono N, et al. The I allele of the angiotensin-converting enzyme gene is associated with anincreased percentage of slow-twitch type I fibers in humanskeletal muscle. Clin Genet 2003; 63 (2): 139–44
Caldiz CI, de Cingolani GE. Insulin resistance in adipocytes from spontaneously hypertensive rats: effect of long-term treatment with enalapril and losartan. Metabolism 1999; 48 (8): 1041–6
Foianini KR, Steen MS, Kinnick TR, et al. Effects of exercise training and ACE inhibition on insulin action in ratskeletal muscle. J Appl Physiol 2000; 89 (2): 687–94
Henriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 1995; 44 (2): 267–72
Linz W, Wiemer G, Scholkens BA. Role of kinins in the pathophysiology of myocardial ischemia: in vitro andin vivo studies. Diabetes 1996; 45 Suppl.1: S51–8
Wicklmayr M, Dietze G, Gunther B, et al. The kallikreinkinin system and muscle metabolism—clinical aspects. Agents Actions 1980; 10 (4): 339–43
Taguchi T, Kishikawa H, Motoshima H, et al. Involvement of bradykinin in acute exercise-induced increase of glucoseuptake and GLUT-4 translocation in skeletal muscle:studies in normal and diabetic humans and rats. Metabolism 2000; 49 (7): 920–30
Hopkinson NS, Eleftheriou KI, Payne J, et al. +9/+9 Homozygosity of the bradykinin receptor gene polymorphismis associated with reduced fat-free mass inchronic obstructive pulmonary disease. Am J Clin Nutr 2006; 83 (4): 912–7
Wagner H, Thaller S, Dahse R, et al. Biomechanical muscle properties and angiotensin-converting enzyme gene polymorphism:a model-based study. Eur J Appl Physiol 2006; 98 (5): 507–15
Montgomery H, Clarkson P, Clarkson P, et al. Angiotensinconverting- enzyme gene insertion/deletion polymorphismand response to physical training. Lancet 1999; 353 (9152): 541–5
Heled Y, Moran DS, Mendel L, et al. Human ACE I/D polymorphism is associated with individual differences inexercise heat tolerance. J Appl Physiol 2004; 97 (1): 72–6
Tanriverdi H, Evrengul H, Tanriverdi S, et al. Improved endothelium dependent vasodilation in endurance athletesand its relation with ACE I/D polymorphism. CircJ 2005; 69 (9): 1105–10
Dengel DR, Brown MD, Ferrell RE, et al. Exercise-induced changes in insulin action are associated with ACE gene polymorphisms in older adults. Physiol Genomics 2002; 11 (2): 73–80
Woods DR, Montgomery HE. Angiotensin-converting enzyme and genetics at high altitude. High Alt Med Biol 2001; 2 (2): 201–10
Kalson N, Thompson J, Davies A, et al. The effect of angiotensin-converting enzyme genotype on acute mountainsickness and summit success in trekkers attemptingthe summit of Mt. Kilimanjaro (5,895 m) Eur J ApplPhysiol 2009; 105 (3): 373–9
Dehnert C, Weymann J, Montgomery HE, et al. No association between high-altitude tolerance and the ACE I/Dgene polymorphism. Med Sci Sports Exerc 2002; 34 (12): 1928–33
Qi Y, Niu W, Zhu T, et al. Synergistic effect of the genetic polymorphisms of the reninangiotensinaldosteronesystem on high-altitude pulmonary edema: a study fromQinghai-Tibet altitude. Eur J Epidemiol 2008; 23 (2): 143–52
Droma Y, Hanaoka M, Basnyat B, et al. Adaptation to high altitude in sherpas: association with the insertion/deletion polymorphism in the angiotensin-convertingenzyme gene. Wilderness Environ Med 2009; 19 (1): 22–9
Patel S, Woods DR, Macleod NJ, et al. Angiotensinconverting enzyme genotype and the ventilatory responseto exertional hypoxia. Eur Respir J 2003; 22 (5): 755–60
Woods DR, Pollard AJ, Collier DJ, et al. Insertion/deletion polymorphism of the angiotensin I-converting enzymegene and arterial oxygen saturation at high altitude. AmJ Respir Crit Care Med 2002; 166 (3): 362–6
Bigham AW, Kiyamu M, León-Velarde F, et al. Angiotensin- converting enzyme genotype and arterial oxygensaturation at high altitude in Peruvian Quechua. High Alt Med Biol 2008; 9 (2): 167–78
Qadar Pasha MA, Khan AP, Kumar R, et al. Angiotensin converting enzyme insertion allele in relation to high altitudeadaptation. Ann Hum Genet 2001; 65 (6): 531–6
Gonzalez AJ, Hernandez D, De Vera A, et al. ACE gene polymorphism and erythropoietin in endurance athletesat moderate altitude. Med Sci Sports Exerc 2006; 38 (4): 688–93
Heled Y, Bloom MS, Wu TJ, et al. CK-MM and ACE genotypes and physiological prediction of the creatinekinase response to exercise. J Appl Physiol 2007; 103 (2): 504–10
Di Bari M, van de Poll-Franse LV, Onder G, et al. Antihypertensive medications and differences in muscle massin older persons: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2004; 52 (6): 961–6
Levine BD. V̇O2max: what do we know, and what do westill need to know? J Physiol 2008; 586 (1): 25–34
Hagerman FC, Connors MC, Gault JA, et al. Energy expenditure during simulated rowing. J Appl Physiol 1978; 45 (1): 87–93
Abraham MR, Olson LJ, Joyner MJ, et al. Angiotensinconverting enzyme genotype modulates pulmonary functionand exercise capacity in treated patients with congestivestable heart failure. Circulation 2002; 106 (14): 1794–9
Hagberg JM, Ferrell RE, McCole SD, et al. VO2 max isassociated with ACE genotype in postmenopausalwomen. J Appl Physiol 1998; 85 (5): 1842–6
Roltsch MH, Brown MD, Hand BD, et al. No association between ACE I/D polymorphism and cardiovascular hemodynamicsduring exercise in young women. Int J Sports Med 2005; 26 (8): 638–44
Woods DR, World M, Rayson MP, et al. Endurance enhancement related to the human angiotensin I-convertingenzyme I-D polymorphism is not due to differences in thecardiorespiratory response to training. Eur J Appl Physiol 2002; 86 (3): 240–4
Bouchard C, Rankinen T, Chagnon YC, et al. Genomic scan for maximal oxygen uptake and its response totraining in the HERITAGE Family Study. J Appl Physiol 2000; 88 (2): 551–9
Bouchard C, Leon AS, Rao DC, et al. The HERITAGE family study: aims, design, and measurement protocol. Med Sci Sports Exerc 1995; 27 (5): 721–9
Zhang X, Wang C, Dai H, et al. Association between angiotensin-converting enzyme gene polymorphisms andexercise performance in patients with COPD. Respirology 2008; 13 (5): 683–8
Kanazawa H, Otsuka T, Hirata K, et al. Association between the angiotensin-converting enzyme gene polymorphismsand tissue oxygenation during exercise inpatients with COPD. Chest 2002; 121 (3): 697–701
Defoor J, Vanhees L, Martens K, et al. The CAREGENE study: ACE gene I/D polymorphism and effect of physicaltraining on aerobic power in coronary artery disease. Heart 2006; 92 (4): 527–8
Welsby IJ, Podgoreanu MV, Phillips-Bute B, et al. Genetic factors contribute to bleeding after cardiac surgery. J Thromb Haemost 2005; 3 (6): 1206–12
Harding D, Baines PB, Brull D, et al. Severity of meningococcal disease in children and the angiotensin-convertingenzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002; 165 (8): 1103–6
Wang P, Fedoruk MN, Rupert JL. Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptorantagonists potential doping agents? Sports Med 2008; 38 (12): 1065–79
Acknowledgements
The authors have no conflicting interests to declare. No funding was received for this article. All contributors have met criteria for authorship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Puthucheary, Z., Skipworth, J.R.A., Rawal, J. et al. The ACE Gene and Human Performance. Sports Med 41, 433–448 (2011). https://doi.org/10.2165/11588720-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11588720-000000000-00000